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Abstract 
Objective: To perform an in vitro analysis of antibacterial and antifungal potential of an alcoholic extract 
from the leaves of Guapira Graciliflora Mart. against oral microorganisms and determine its chemical 
composition. Material and Methods: A hydroalcoholic extract of the leaves form G. graciliflora was 
obtained through maceration, vacuum concentration and freeze-drying. Antibacterial and antifungal 
activities were evaluated against Streptococcus mutans, Streptococcus salivarius, Streptococcus oralis, Streptococcus 
parasanguinis, Streptococcus mitis and strains of Candida albicans using broth microdilution method. 
Phytochemical analysis determined the total phenolic compounds, protein concentration and total of sugars 
present in the extract. Results: G. Graciliflora demonstrated antifungal activity against the LM 11 and LM 
410 clinical isolates of C. albicans (MIC 0.5 mg/mL and 2 mg/mL, respectively). The other microorganisms 
tested were resistant to the extract. The phytochemical analysis revealed 3% proteins, 13% total sugars and 
17% phenolic compounds. Conclusion: G. Graciliflora has antifungal activity against clinical strains of C. 
albicans and exhibits proteins, sugars and phenolic compounds in its chemical composition. 
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Introduction 
The oral cavity is an important site regarding the complexity and diversity of its microbiome, it has a 
complex ecosystem with over 700 identified species [1,2] in which fungi and bacteria gained relevance due to 
its correlation with prevalent infections such as oral candidiasis [3], periodontal diseases [4], and dental caries 
[5]. However numerous strains of bacteria and fungi have developed resistance to the action of conventional 
antimicrobial agents, possibly as a consequence of the indiscriminate use of antibiotics by the population [6-8]. 
The interest in natural products, such as medicinal plants, has grown in the primary health care 
setting since plants represent an excellent source of biologically active agents for the development of products 
of medical and dental interest [9]. Guapira Graciliflora Mart. belongs to the family Nyctaginacea and is 
commonly found in the Caatinga semi-arid biome of northeastern Brazil [10,11]. This plant is used as a folk 
remedy and demonstrates antimicrobial activity [12,13] and anticandidal activity [14]. 
Identification of a novel antimicrobial agents can contribute in the treatment of oral conditions that 
are considered public health problems, such as dental caries and oral candidiasis. Therefor in vitro studies with 
microorganisms of oral interest are important and must be conducted. Additionally, this study proposes to use 
G. graciliflora leaves obtained in the semi-arid region of the state of Paraíba in northeastern Brazil in a winter 
time, studies has shown that geographic location and environmental conditions may have influence on the 
plant chemical composition [15,16]. 
Thus, the aim of the present study was to evaluate the antimicrobial potential of a hydroalcoholic 
extract from the leaves of Guapira Graciliflora Mart. against microorganisms related to these diseases and 
determine its chemical composition. 
 
Material and Methods 
Vegetal Material and Obtainment of Alcoholic Extract 
Leaves of G. Graciliflora Mart. were collected from a rural area of the municipality of Queimadas in the 
semi-arid region of the state of Paraíba in northeastern Brazil between July and August 2012. The material 
was cleaned, placed in paper bags and dehydrated in a laboratory incubator (Fanem 330, Fanem Ltda., São 
Paulo, SP, Brazil) at 40°C. A voucher specimen was deposited in the collection of the Manuel de Arruda 
Câmara Herbarium of the State University of Paraíba, Campus I, Campina Grande, Brazil (n° 907/ ACAM). 
The extraction process involved maceration for five days, using a proportion of 200 grams of dried, ground 
leaves to one liter of 50% ethanol. The extract was vacuum concentrated in a rotary evaporator Q344M 
(Quimis Aparelhos Científicos, Diadema, SP, Brazil) at 40°C and the residual portion was freeze dried 
(Labconco Freezone 4.5, Labconco Corp., Kansas City, MO, USA) [16]. 
 
Antimicrobial Assays 
Microbial Growth Conditions 
Six bacterial strains - Streptococcus mutans (ATCC 25175), Streptococcus salivarius (ATCC 7073), 
Streptococcus oralis (ATCC 10557), Streptococcus parasanguinis (ATCC 903), Streptococcus mitis (ATCC 49456) and 
Candida albicans (ATCC 18804) and clinical isolates of the yeast Candida albicans (LM 11 and LM 410) were 
acquired from the Antimicrobial Research Laboratory of the State University of Paraíba. Bacteria and yeast 
were activated in brain heart infusion (BHI) and in sabouraud dextrose agar medium respectively; the plates 
were incubated at 37ºC (SP Labor Equipamentos Para Laboratórios, São Paulo, SP, Brazil) for 24 h in either an 
aerobic or microaerophilic atmosphere (Anaerobic Jar Permution, Curitiba, PR, Brazil) [17,18].
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Determination of Minimum Inhibitory Concentration (MIC) 
The broth microdilution method was used for the determination of the minimum inhibitory 
concentration (MIC). Using a 96-well plate, 100 µl/well of culture medium (BHI agar for bacteria and 
sabouraud dextrose agar for yeasts) and 100 µl of G. graciliflora were added to the first well of each row to 
begin the serial microdilution process. Next, 100 µl/well of inoculum (5 x 105 colony forming units/mL for 
bacteria and 2.5 x 103 colony forming units/mL for yeasts) were added. The plates were incubated at 37ºC (SP 
Labor Equipamentos Para Laboratórios, São Paulo, SP, Brazil) for 24 h in either an aerobic or microaerophilic 
atmosphere (Anaerobic Jar Permution, Curitiba, PR, Brazil), depending on the microorganism [17,18]. The 
positive controls were chlorhexidine (Sigma-Aldrich Brasil, Merck KGaA, Darmstadt, Germany) for bacteria 
and nystatin (Sigma-Aldrich Brasil, Merck KGaA, Darmstadt, Germany) for yeasts. Individual wells of the 
microplates were used to determine the control growth of the microorganism as well as the sterility of the 
culture medium, vegetal material and vehicle. 
After the incubation period, 50 mL/well of 0.01% resazurin solution (Sigma-Aldrich Brasil, Merck 
KGaA, Darmstadt, Germany) were added and the MIC was defined as the lowest concentration of extract 
capable of impeding the appearance of red coloration in the medium when the cells demonstrated respiratory 
activity. The following criteria were used for the classification of the antimicrobial activity of the extract: MIC 
< 100 µg/mL = strong activity; MIC between 100 and 500 µg/mL = moderate activity; MIC between 500 and 
1000 µg/mL = weak activity; and MIC > 1000 µg/mL = no activity [19]. 
 
Determination of Minimum Bactericidal/Fungicidal Concentration (MBC/MFC) 
For the determination of the MBC and MFC, a 50 µL aliquot of the MIC and a concentration above 
the MIC were sub-cultivated in BHI agar medium (bacteria) or sabouraud dextrose agar medium (yeasts) and 
incubated at 37°C for 24 h. The MBC and MFC were defined as the lowest concentration that inhibited visible 
growth in the medium. 
 
Phytochemical Analysis  
Total Phenolic Compounds 
The content of total phenolic compounds was determined using the Folin-Ciocalteau 
spectrophotometric method, with gallic acid as the reference standard [20]. The reading was performed in a 
spectrophotometer 600S (FEMTO Indústria e Comércio de Instrumentos, São Paulo, SP, Brazil) at 765 nm. 
 
Protein Concentration 
The concentration of protein was determined using the Bradford reagent [21]. Bovine serum albumin 
was used as the standard. The reading was performed at 595 nm in a microplate reader (Epoch, Biotek, Gen5 
Data Analysis Software, Winooski, USA). 
 
Total Sugars 
The quantification of sugars was determined using the Dubois method through the formation of 
furfural compounds following the dehydration of sugars by sulfuric acid (A.R.) [22]. The reading was 
performed in a spectrophotometer 600S (FEMTO Indústria e Comércio de Instrumentos, São Paulo, SP, 
Brazil) at 490 nm. 
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Results 
The G. graciliflora extract exhibited antimicrobial activity against the clinical isolates of Candida 
albicans, with moderate potential regarding strain 11 (MIC: 0.5 mg/mL) and weak potential regarding strain 
410 (MIC: 2 mg/mL), based on the classification described by some authors [19]. The other microorganisms 
tested were resistant to the extract (Table 1). Regarding the chemical composition it was revealed that the 
extract was 3% proteins, 13% total sugars and 17% phenolic compounds. 
 
Table 1. Minimum inhibitory concentration (MIC) and minimum bactericidal/fungicidal concentration 
of G. graci l i f lora  extract. 
Microorganism 
Extract (mg/mL-1) Chlorhexidinec Nystatinc 
MIC MBC MFC MIC MBC MIC MFC 
S. mutans R R - H H - - 
S. salivarius R R - H H - - 
S. oralis R R - H H - - 
S. parasanguinis R R - H H - - 
S. mitis R R - H H - - 
C. albicans R - R - - H H 
C. albicans (LM 11)* 0.5 - 1 - - H H 
C. albicans (LM 410)* 2 - 2 - - H H 
MBC: Minimum Bactericidal Concentration; MFC: Minimum Fungicidal Concentration; *Clinical strain; cPositive Control; R: Resistant; 
H: Concentration of Last Well. 
 
Discussion 
Based on the criteria established by another study [19] the antifungal activity of G. graciliflora extract 
was classified as moderate for the LM11 clinical strain of C. albicans. The antifungal activity of this extract was 
also established in a previous work [14], however different strains of Candida were used. C. albicans are 
considered the etiological factor of oral candidiasis, it has been isolated in about 50% of the cases, therefore 
considering the consequences of oral candidiasis this is an important finding in the search for effective 
antifungal agents against the progression of this infection, especially in immunocompromised patients [23-25]. 
G. graciliflora extract didn’t exhibit antibacterial activity diverging from the literature. Some authors 
[13] investigated the potential of G. graciliflora using hydroalcoholic extracts of the leaves and bark and 
demonstrated antimicrobial activity against the following bacteria associated with endodontic infection: S. 
aureus (12.50 and 12.50 µL/µL), E. faecalis (12.50 and 6.25 µL/µL) and E. coli (12.50 and 6.25 µL/µL). The 
ethanol extract from the stems of G. Graciliflora Mart. demonstrated antimicrobial action against S. aureus, E. 
coli, P. aeruginosa (MIC ≥ 1024 µg/mL) and K. pneumoniae (MIC = 512 µg/mL) [12]. 
The divergences in the results may be explained by differences in the parts of the plant employed, the 
extraction method, and time of year in which the vegetal material was collected, which are factors that exert an 
influence on the compounds obtained and the bioactive activities of the extracts [26,27]. The antimicrobial 
activity of an extract occurs through the combined action of the chemical compounds in the plant rather than 
by the isolated activity of each compound [26]. 
Regarding the G. graciliflora extract used in this study, chemical analysis revealed proteins, sugars and 
phenolic compounds, additionally, phytochemical profile stablished in a previous study showed the presence of 
flavonoids rutin and kaempferol as well as the polyol pinitol [14]. The phytochemical characterization of 
vegetal species is fundamental, as such species are rich in bioactive substances that are useful to the 
development of therapeutic agents [28]. Studies involving the phytochemical characterization of plants from 
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the family Nyctaginaceae have also revealed the presence of secondary metabolites belonging to the flavonoid, 
carotenoid, betacyanin, alkaloid and saponin groups [10,29,30] 
Rutin and kaempferol are known for their antioxidant, antitumor, antimicrobial and anti-inflammatory 
effects [31] and have demonstrated antimicrobial activity against Staphylococcus aureus, Escherichia coli, 
Enterococcus faecalis, Pseudomonas aeruginosa, Proteus mirabilis, Bacillus subtilis and C. albicans [32,33]. These 
compounds can inactivate enzymes and form complexes with proteins in the cell wall of microorganisms, which 
are likely the mechanisms of action for the present study [34,35]. Phenolic compounds, as phenols are also 
good antimicrobials [36,37] and polyols, such as pinitol, are products of the metabolism of carbohydrates and 
are associated with strong antioxidant activity [38]. 
The present results underscore the need for further biological assays involving G. graciliflora. The 
need for more tests to seek the confirmation of the antifungal activity must be conducted, and it is a limitation 
of this study, more species of Candida should be tested since it demonstrated a moderate potential against a 
fungal stain tested, and therefore give continuity to studies that seek bioactive substances for the development 
of novel antimicrobial drugs [39] since studies have already shown the growth in the resistance against 
conventional antimicrobial agents [6-8]. Additionally, toxicological studies must be done to assure its safety 
when used by the general population [40]. 
 
Conclusion 
The extract from the leaves of G. graciliflora has proteins, sugars and phenolic compounds in its 
chemical composition and exhibits antifungal activity, capable of in vitro inhibition of the growth of clinical 
isolates of C. albicans. 
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